Menu
GeneBe

20-50581418-C-T

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_002827.4(PTPN1):​c.1242C>T​(p.Cys414=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00283 in 1,613,624 control chromosomes in the GnomAD database, including 109 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 50 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 59 hom. )

Consequence

PTPN1
NM_002827.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.12
Variant links:
Genes affected
PTPN1 (HGNC:9642): (protein tyrosine phosphatase non-receptor type 1) The protein encoded by this gene is the founding member of the protein tyrosine phosphatase (PTP) family, which was isolated and identified based on its enzymatic activity and amino acid sequence. PTPs catalyze the hydrolysis of the phosphate monoesters specifically on tyrosine residues. Members of the PTP family share a highly conserved catalytic motif, which is essential for the catalytic activity. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP has been shown to act as a negative regulator of insulin signaling by dephosphorylating the phosphotryosine residues of insulin receptor kinase. This PTP was also reported to dephosphorylate epidermal growth factor receptor kinase, as well as JAK2 and TYK2 kinases, which implicated the role of this PTP in cell growth control, and cell response to interferon stimulation. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 20-50581418-C-T is Benign according to our data. Variant chr20-50581418-C-T is described in ClinVar as [Benign]. Clinvar id is 789498.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.12 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0144 (2197/152278) while in subpopulation AFR AF= 0.0492 (2044/41528). AF 95% confidence interval is 0.0474. There are 50 homozygotes in gnomad4. There are 1068 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2197 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PTPN1NM_002827.4 linkuse as main transcriptc.1242C>T p.Cys414= synonymous_variant 9/10 ENST00000371621.5
PTPN1NM_001278618.2 linkuse as main transcriptc.1023C>T p.Cys341= synonymous_variant 8/9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PTPN1ENST00000371621.5 linkuse as main transcriptc.1242C>T p.Cys414= synonymous_variant 9/101 NM_002827.4 P1
PTPN1ENST00000541713.5 linkuse as main transcriptc.1023C>T p.Cys341= synonymous_variant 8/92

Frequencies

GnomAD3 genomes
AF:
0.0143
AC:
2182
AN:
152160
Hom.:
50
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0490
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00589
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000828
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000412
Gnomad OTH
AF:
0.0148
GnomAD3 exomes
AF:
0.00381
AC:
957
AN:
251054
Hom.:
28
AF XY:
0.00268
AC XY:
363
AN XY:
135688
show subpopulations
Gnomad AFR exome
AF:
0.0513
Gnomad AMR exome
AF:
0.00220
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000980
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000291
Gnomad OTH exome
AF:
0.00179
GnomAD4 exome
AF:
0.00162
AC:
2370
AN:
1461346
Hom.:
59
Cov.:
31
AF XY:
0.00140
AC XY:
1015
AN XY:
726868
show subpopulations
Gnomad4 AFR exome
AF:
0.0520
Gnomad4 AMR exome
AF:
0.00302
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.000197
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000174
Gnomad4 OTH exome
AF:
0.00432
GnomAD4 genome
AF:
0.0144
AC:
2197
AN:
152278
Hom.:
50
Cov.:
32
AF XY:
0.0143
AC XY:
1068
AN XY:
74470
show subpopulations
Gnomad4 AFR
AF:
0.0492
Gnomad4 AMR
AF:
0.00588
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000622
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000412
Gnomad4 OTH
AF:
0.0147
Alfa
AF:
0.00939
Hom.:
24
Bravo
AF:
0.0164
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000119

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

PTPN1-related disorder Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesMar 12, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeDec 13, 2017- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
10
DANN
Benign
0.91

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs74607837; hg19: chr20-49197955; API